Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 7.3B | 7.0B | 6.5B | 8.2B |
Cost of revenue | 4.8B | 4.5B | 4.2B | 5.5B |
Gross profit | 2.5B | 2.5B | 2.3B | 2.7B |
Operating expense | ||||
Research & development | 223.4M | 222.8M | 203.2M | 344.2M |
Selling general and admin | 809.7M | 535.9M | 507.7M | 624.3M |
Other operating expenses | — | — | — | — |
Operating income | 1.5B | 1.8B | 1.6B | 1.8B |
Non operating interest income | ||||
Income | 30.9M | 8.7M | 28.3M | 26.1M |
Expense | 111.1M | 103.4M | 103.9M | 157.0M |
Other income expense | — | — | — | — |
Pretax income | 1.5B | 1.8B | 1.4B | 1.8B |
Tax provision | 360.9M | 378.6M | 214.4M | 394.2M |
Net income | 2.1B | 2.6B | 2.0B | 1.4B |
Basic EPS | — | 2.0 | 1.6 | 1.1 |
Diluted EPS | — | 2.0 | 1.6 | 1.1 |
Basic average shares | — | 1.2B | 1.2B | 1.2B |
Diluted average shares | — | 1.2B | 1.2B | 1.2B |
EBITDA | 3.2B | 3.5B | 3.3B | 4.3B |
Net income from continuing op. | 2.8B | 3.3B | 2.4B | 1.8B |
Minority interests | -92.9M | -106.5M | -77.5M | -38.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |